A Phase II Clinical Study of Surufatinib Combined With Sintilimab in the Treatment of Advanced Gastric Cancer
Clinical trial NCT05235906 · UNKNOWN
Trial details
- NCT number
- NCT05235906
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-16
- Primary completion
- 2024-03-31
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.